Chennai-based fertility care provider Iswarya raises Rs 350 crore from OrbiMed Asia

Chennai-based fertility care provider Iswaryatoday announced a growth investment of more than Rs 350 crore (approximately $37 million) from OrbiMed Asia (OrbiMed), a global healthcare investment firm.

Established in 1986 and led by Managing Director Dr. Arun Muthuvel, Iswarya offers services spanning from IVF, IUI, fertility preservation, genetics, and advanced reproductive treatments.

The firm claims it has South India’s largest fertility network with 85+ centers across eight states, serving more than 300,000 couples over four decades.

Iswarya said it will use the raised capital to establish new centers in existing and underserved markets, strengthen clinical infrastructure, invest in digital capabilities and expand its embryology talent pipeline.

"For nearly four decades, Iswarya has been driven by a single purpose — making parenthood possible. Our focus over the next phase is clear: deepen our pan-India presence, enter underserved geographies and keep raising the bar on clinical outcomes. We will invest in our people, technology and patient experience, ensuring that excellence remains at the heart of everything we do,” said Dr. Arun Muthuvel.

“Iswarya has established itself as one of the country’s leading fertility platforms through its strong clinical outcomes, trusted brand, capital-efficient operating model, and experienced leadership team. We are delighted to partner with Dr. Arun, Dr. Chandralekha, and the entire management team as they continue to build a category-defining fertility care platform,” said Dr. Sunny Sharma, Partner and Senior Managing Director, and Arun Sadhanandham, Managing Director at OrbiMed.

Looking ahead, Iswarya will deepen its presence in existing markets, enter underserved geographies and continue investing in clinical excellence, medical education and innovation.